Pulmonary Nodule Localization Prospective Validation

Sponsor
E-DA Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04690790
Collaborator
(none)
50
1
11.2
4.4

Study Details

Study Description

Brief Summary

Localization is the key for successful excision of small target nodules under thoracoscopy, but the procedure also brings risks to patients. However, the criteria is still unclear. The investigators will validate the prediction model produced by institutional retrospective analysis in the prospective cohort.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Thoracoscopy

Detailed Description

Excision of targeted lung nodules during thoracoscopy sometimes needs placing a mark before surgery. The procedure of mark placement (localization) could probably cause damages to the patients. However, the criteria for patient selection is still not clear. Through respective analysis, the investigators have set up a prediction model and wish to validate this model prospectively.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pulmonary Nodule Localization Under Thoracoscopic Surgery- a Machine Learning Based Retrospective Analysis and Prospective Validation
Actual Study Start Date :
Jan 23, 2021
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Outcome Measures

Primary Outcome Measures

  1. Nodule detection [During surgery]

    Whether the nodule could be detected by conventional visualization or palpation

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≧ 20 years

  • Lung nodule size ≦2cm on the pre-operative computed tomography (CT)

  • Nodulectomy is performed under thoracoscopy

Exclusion Criteria:
  • Age < 20 years

  • Lung nodule size > 2cm on CT or in the final pathology report

  • Open surgery for nodulectomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 E-DA Hospital Kaohsiung Taiwan 824

Sponsors and Collaborators

  • E-DA Hospital

Investigators

  • Principal Investigator: Ming-Wei Kao, M.D., M.S., E-DA Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tu, Yuan-Kun, president, E-DA Hospital
ClinicalTrials.gov Identifier:
NCT04690790
Other Study ID Numbers:
  • EMRP56109N
First Posted:
Dec 31, 2020
Last Update Posted:
Jan 26, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tu, Yuan-Kun, president, E-DA Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2021